Article Information
- June 13, 2024.
Article Versions
- Version 1 (June 7, 2024 - 11:07).
- You are viewing Version 2, the most recent version of this article.
REVISION SUMMARY
Author Jayne Y. Hehir-Kwa was erroneously omitted from the author list within the PDF-version, so has been added now. Final models were rerun to allow for their submission to Zenodo (no possible linking to patient samples). Small alterations were observed in performance, so figures were updated to reflect this change. The link to the Zenodo submission is added to the manuscript. The word 'malignancy' has been replaced with tumors, to reflect the fact that there are also benign tumors covered within our cohort. The paragraph 'Obtaining patient material and RNA-seq data' was missing from the Method section - it has now been added.
Author Information
- Fleur S.A. Wallis1,
- John L. Baker-Hernandez1,
- Marc van Tuil1,
- Claudia van Hamersveld1,
- Marco J. Koudijs1,
- Eugène T.P. Verwiel1,
- Alex Janse1,
- Laura S. Hiemcke-Jiwa1,2,
- Ronald R. de Krijger1,2,
- Mariëtte E.G. Kranendonk1,
- Marijn A. Vermeulen1,
- Pieter Wesseling1,3,
- Uta E. Flucke1,
- Valérie de Haas1,
- Maaike Luesink1,
- Eelco W. Hoving1,
- H. Josef Vormoor1,4,
- Max M. van Noesel1,5,
- Jayne Y. Hehir-Kwa1,
- Bastiaan B.J. Tops1,
- Patrick Kemmeren1,6,* and
- Lennart A. Kester1,*
- 1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
- 2Department of Pathology, UMC Utrecht, Utrecht, The Netherlands;
- 3Department of Pathology, Amsterdam University Medical Centers/ VUmc, Amsterdam, The Netherlands;
- 4Utrecht Cancer Center, UMC Utrecht, Utrecht, The Netherlands;
- 5Division Imaging & Cancer, UMC Utrecht, Utrecht, The Netherlands;
- 6Center for Molecular Medicine, UMC Utrecht & Utrecht University, Utrecht, the Netherlands;
- ↵*corresponding authors; email: l.a.kester{at}prinsesmaximacentrum.nl